Erlanger Behavioral Health Hospital today reinforced its strong commitment to the communities it serves by opening 48 new beds at a new satellite location. The hospital held a ribbon-cutting event at the additional location – located at 632 Morrison Springs Road in Chattanooga – to mark this momentous occasion and celebrate the joint venture partnership… Read More
inTRAvent Medical Partners LP, a medical device company dedicated to bringing intra-operative imaging and navigation to the bedside to improve neurosurgical procedures, today announced the appointment of Kevin Foley, MD, in the newly created role of Chief Innovation Officer (CIO).
Spectral AI, Inc. an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced the addition of seven clinical sites that are currently enrolling to support the development of its diabetic foot ulcer (DFU) application for the DeepView® Wound Imaging System. Participating investigators and clinical… Read More
Ten forward-thinking organizations honored for innovative and impactful use of the Paylocity HCM platform during the company’s annual Elevate Conference University Clinical Health – the only independent and physician-led faculty practice plan of the University of Tennessee Health Science Center.
AdhereHealth, a healthcare technology leader in medication adherence insights and health outcomes, announced today that CEO, Jason Rose, will join the University of Tennessee Health Science Center (UTHSC) College of Pharmacy’s (COP) continuing education program to discuss medication adherence and its impact on the quintuple aim of healthcare. The series of live virtual events will take place on September… Read More
A graduate of the University of Tennessee and University of Tennessee Health Science Center (UTHSC) College of Dentistry, Dr. Wenk has supported his alma maters through fundraising campaigns and the recent chancellor search. He has served as the chair of the UTHSC Advisory Board since it began in 2019 and is the immediate past chair… Read More
In June 2023, the Company announced that The University of Tennessee Health Science Center (UTHSC), oncology drug discovery research partner to Veru Inc., secured two additional grants to develop oncology therapeutics for indications of high unmet need. UTHSC was awarded $924,000 from the U.S. Department of Defense (DoD) and $3,074,470 from the National Cancer Institute’s… Read More
“It is great to have long term follow up on this large, adjudicated GCP study. At this time, there is no device that has been shown to be safer for aneurysm patients than WEB. So, if a patient with a wide-neck bifurcation aneurysm can be treated with WEB, that ought to be the primary consideration,”… Read More
